针对局部治疗的免疫球体GFc工程:消除新生儿Fc受体相互作用,并使用蛋白A确保净化
Akifumi Kato1, Asami Toshima2, Gennosuke Takekawa1
1Innovation Center, Research Division, Kyowa Kirin Co., Ltd, Tokyo, Japan.
Protein science : a publication of the Protein Society
|October 22, 2025
概括
研究人员设计了抗体疗法,以减少局部治疗的副作用. 抗体中的H435F替代加速了清除,并保持了净化效率,提高了治疗潜力.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 单克隆抗体 (mAbs) 和双特异性抗体 (bsAbs) 是重要的治疗药物.
- 系统性管理可能会导致不良反应和局部输送不良.
- 修改Fc区域以减少新生儿Fc受体 (FcRn) 的结合,可能会提高局部抗体治疗的安全性.
研究的目的:
- 研究IgG Fc区域中的氨基酸替代,以消除FcRn结合,同时保持蛋白A对抗体净化的亲和力.
- 评估这些替代物的药理动力学影响,特别关注清除和半衰期.
- 评估蛋白质A染色体对用修饰的Fc区域净化抗体的疗效.
主要方法:
- 在关键的Fc区域残留物 (I253,H310,H435,Y436) 中研究了多种氨基酸替代.
- 评估了FcRn和蛋白质A对工程抗体变异的结合亲和力.
- 在人类FcRn转基因小鼠中评估了血清半衰期和清除.
- 进行蛋白A色谱,以确定净化效率和产量.
主要成果:
- H435F的替代有效地消除了FcRn的结合.
- 蛋白质A的亲和力与H435F替代保持在一起.
- 在体内,H435F导致清除加速,血清半衰期缩短.
- 蛋白质A染色学是有效的净化没有显著的产量损失.
结论:
- H435F替代是一种有希望的策略,用于优化局部治疗应用的抗体药理动力学.
- 这种修改可以减少系统性暴露和潜在的副作用.
- 这些发现支持使用已知的净化方法开发用于局部治疗的工程抗体.
相关概念视频
Immunoprecipitation
6.7K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
6.7K
Transcytosis of IgG
4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K


